report strong result even w/o benefit due find re-affirmed
guid encourag despit impli lower result remaind given increment
cost lower invest inc add interest exp suggest still solid
l-t fundament addit acceler digit strategi
like sustain benefit
impact thesi remain fundament sound
remain posit given strong underli perform quarter ex-
rais estim pt slightli believ
outlook cautiou could prove conserv see futur opportun
due pandem realiz benefit impli
adj ep still well ahead consensu specif total
adj claim grew script dispens retail/ltc grew metric
would beaten consensu est addit prior saw f-e compstore comp
notabl re-affirmed guidanc impli weaker result
remaind year base strong beat think management like
prudent given multitud possibl recoveri scenario believ
could prove conserv find particularli encourag management re-affirmed
guidanc expect realiz increment expens relat lower net
invest incom higher interest expens per quarter furthermor think
consumer-centr digit strategi could benefit pandem believ
sustain world consum behavior chang
saw high level engag across digit asset exampl util virtual
visit minuteclin y/i retail prescript home deliveri
y/i fourfold increas number consum ad f-
 item prescript deliveri y/i double-digit percentag increas app
usag across pharmaci caremark specialti
result solid out-performance across segment relat activ
estim ad cent adj ep even exclud adj ep
would still handili beat consensu furthermor note
underli core growth strong even prior highlight includ
pbm estim impact total pharmaci claim growth
bp pharmaci servic sell reason renew
complet retent rate rang
click read full report
pleas see page report import disclosur
posit long-term strategi coordin care combin
legaci asset aet broader healthcar system continu transit toward
value-bas care believ potenti bring differenti model
market gain share and/or improv profit demonstr
valu proposit market management believ improv outcom lower cost
manag chronic condit use healthhub leverag telemedicin non-
physician provid furthermor view share under-valued current level
progress integr aet
merger achiev synergi target
increment inform l-t
strategi potenti revenu
top-lin growth
adj oper margin almost
assum share repo
top-lin growth greater due
lower expect impact
adj oper margin higher
expect benefit faster
greater contribut gener
lower expect impact
expect
top-lin growth weaker due
wors expect impact
adj oper margin lower
expect slower synergies/
contribut gener wors
expect impact
one largest drug retail chain compani larg oper
two main busi segment pharmaci servic retail pharmaci
retail pharmaci segment compani oper drugstor on-line retail
pharmaci websit well health clinic store sell prescript drug
wide array gener merchandis refer front end product
compani also provid full rang pbm servic client mainli includ
organ sponsor health benefit plan servic includ formulari
servic diseas manag program pharmacogenom servic
retail/ltc estim impact prescript fill growth
bp front-end revenue growth also benefit prior management
estim front-end revenue y/i still encourag retail pharmaci
home deliveri y/i telemedicin virtual visit
minuteclin y/i
hcb note pressur medicaid due longer flu season
high cost claimant although hcb bp better estim
note cdc talk elev flu season past oper profit
growth weaker management prior guid due medicaid
mbr well onboard illinicar strand cost relat aetna
pdp divestitur howev item appear structur believ
revers eventu
provid earli read april busi updat prescript volum
retail/ltc pharmaci servic flat y/i april driven revers
prescript pull forward march fewer prescript new therapi start
april y/i
retail side pharmaci sale still y/i april better
model although could season bake note
see declin mail specialti rel retail expect
given rel inelast demand deliveri y/i
also help off-set headwind pharmaci front store sale
april shelter-in-plac order reduc foot traffic howev expect may start
improv state reopen point comment front-end compstore
mid-teen first week april show sign improv later
april note certain store resum normal hour oper well
front store sale ad prescript deliveri help off-set
health benefit side note could lowest level
earli data suggest util decreas echo commentari
manag care name report earlier last week expect util
ramp due pent-up demand state reopen also would
expect medicaid enrol could step unemploy increas commerci
enrol come
re-affirmed adj ep guidanc op cash flow
find particularli encourag management re-affirmed guidanc expect realiz
increment expens relat lower net invest incom higher interest
updat estim price
rais adj ep est
respect also rais pt base revis dcf analysi
impli share trade adj ep estimate
million except per-shar data
cowen compani
interseg net good interseg net cost good benefit interseg net benefit gross gross bp chang oper oper oper bp chang adj oper adj oper bp chang interest expens pre-tax pre-tax bp chang adj incom tax provis effect tax rate effect tax adj net adj net incom bp chang earn alloc particip net incom attribut non-controlling adj net incom attribut net weight averag dilut share adj pharmaci servic gross gross adj oper adj oper total adj gross profit/adj retail/ltc gross gross oper oper retail store increas decreas total pharmaci front store benefit oper oper cowen
million except per-shar data
cowen compani
model assumptionstermin growth tax depreci chang net work terminal- valuefre pv npv free npv futur excess valu total number valu per year end decemb cowen
million except per-shar data
cowen compani
interseg net good interseg net cost good benefit interseg net benefit gross gross chang y/y- oper oper chang y/y- adj oper adj oper chang y/y- interest expens pre-tax pre-tax chang y/y- adj incom tax provis effect tax rate tax net adj net incom chang y/y- earn alloc particip net incom attribut non-controlling adj net incom attribut net weight averag dilut share adj chang y/i net oper net net incom attribut end decemb cowen
million except per-shar data
cowen compani
interseg net good interseg net cost good benefit interseg net benefit gross gross chang oper oper chang adj oper adj oper chang interest expens pre-tax pre-tax chang adj incom tax provis effect tax rate tax net adj net incom chang earn alloc particip net incom attribut non-controlling adj net incom attribut net weight averag dilut share adj chang y/i net oper net net incom attribut cowen
million
cowen compani
cash short-term account receiv current current long-term properti equip oper leas right-of-us assets- intang asset separ account assets- total liabil account pharmaci claim discount care cost policyhold funds- accru insur current portion oper leas liabilities- short-term current portion long-term current long-term long-term oper leas liabilities- defer incom separ account liabilities- long-term insur long-term redeem non-controlling interest- stockhold equiti common treasuri retain accumul comprehens total sharehold non-controlling total sharehold total liabil stockhold short-term liquid ratio current sale day purchas account day claim day ratio inventori capit structur long-term solvenc ratio total debt total interest ratio return invest capit averag total asset averag stockhold equiti decemb cowen
million
compani report cowen compani
income/ loss adjust requir reconcil net incom net cash provid oper activ depreci goodwil impairments- loss settlement defin benefit pension plans- stock-bas loss sale loss earli extinguish defer incom tax non-cash chang oper asset liabil net effect acquisit account receiv account payabl claim discount care cost payabl insur long-term net cash oper acquisit proce sale subsidiari assets- properti acquisit issuanc common purchas treasuri stock- dividend proceeds/ purchas secur proceeds/ repay debt net increase/ decreas cash equival restrict cash begin cash equival restrict cash end cowen summari capit owner financ non-recur exclud non-recur itemsyear end decemb cowen
million
compani report cowen compani
activitiesnet adjust requir reconcil net incom net cash provid oper activ depreci goodwil impairments- loss settlement defin benefit pension plans- stock-bas loss sale subsidiary- loss earli extinguish defer incom tax non-cash chang oper asset liabil net effect acquisit account receiv account payabl pharmaci claim discount care cost payabl insur long-term net cash provid oper invest activitiesproce sale matur purchas purchas properti proce sale-lease-back acquisit net cash proce sale subsidiari assets- net cash use invest financ activitiesincreas decreas short-term proce issuanc long-term repay long-term purchas non-controlling interest payment conting deriv settlements- dividend proce exercis stock payment tax relat net share settlement equiti repurchas common net cash provid use financ effect exchang rate net decreas cash cash cash equival restrict cash begin cash equival restrict cash end year end decemb cowen
use five-year discount cash flow analysi primari valuat method
deriv price target gener assum discount rate may appli
appropri adjust depend compani and/or industri specif factor also
assum termin growth rate depend long-term view specif
sub-industri coverag note discount rate assumpt could view
conserv rel actual weight averag cost capit view
assumpt reason long run lower discount rate assumpt
increas termin growth rate assumpt would lead higher estim valu
per share secondari measur look forward price-to-earnings multipl ev/sal ratio
impli dcf analysi compar histor averag
see number risk associ drug retail space industri highli
competit retail drugstor chain independ pharmaci mail-ord provid
well retail includ groceri store mass merchant warehous club on-line
store compet space could pressur front-end sale margin
current wave drug patent expir posit impact profit
deriv gener expect taper significantli next sever year
specialti provid signific tailwind part believ
could concern around sustain high growth area
believ impact ppaca expect increas volum could subdu
depend implement execut
slower expect realiz integr synergi and/or enterpris
modern benefit lower expect benefit transform initi
political/regulatori chang advers affect signific contract loss
